Pharma Pricing and Market Access
102 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Edmond Rama
Scoop.it!

Germany may publicize its drug discounts, putting fear into Big Pharma's heart - FiercePharma

Germany may publicize its drug discounts, putting fear into Big Pharma's heart - FiercePharma | Pharma Pricing and Market Access | Scoop.it
Germany may publicize its drug discounts, putting fear into Big Pharma's heart
FiercePharma
But details of those price cuts, or so-called "patient access schemes," have never been released, and the government has no plans to do so.
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

Eli Lilly jumps after cancer drug trial - Financial Times

Eli Lilly jumps after cancer drug trial - Financial Times | Pharma Pricing and Market Access | Scoop.it
Eli Lilly jumps after cancer drug trial
Financial Times
By Eric Platt in New York.
more...
No comment yet.
Rescooped by Edmond Rama from Econ 3
Scoop.it!

Biggest ever takeover in the pharmaceutical industry"Actavis to buy Forest Labs for $25bn"

Biggest ever takeover in the pharmaceutical industry"Actavis to buy Forest Labs for $25bn" | Pharma Pricing and Market Access | Scoop.it

The world's second-largest generic drugmaker Actavis is buying Forest Laboratories for about $25bn (£15bn) in its biggest-ever acquisition.


Via Jiten Mistry
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

Germany looks again at Fycompa pricing - PMLiVE

Germany looks again at Fycompa pricing - PMLiVE | Pharma Pricing and Market Access | Scoop.it
Germany looks again at Fycompa pricing PMLiVE Last year, Eisai made headlines after it decided to withdraw Fycompa (perampanel) from the market rather than sell it at the price approved by the Germany's health technology assessment (HTA) agency,...
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

Drug Firms Look to Gulf Region as Next Frontier - Wall Street Journal

Drug Firms Look to Gulf Region as Next Frontier - Wall Street Journal | Pharma Pricing and Market Access | Scoop.it
Drug Firms Look to Gulf Region as Next Frontier
Wall Street Journal
"Diabetes is a public-health issue but at the same time it creates opportunities for the pharmaceutical industry," says Jan Schmitz-Huebsch, consultant with Booz & Co.
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

EU gives boost to its network of HTA bodies - PMLiVE

EU gives boost to its network of HTA bodies - PMLiVE | Pharma Pricing and Market Access | Scoop.it
EU gives boost to its network of HTA bodies PMLiVE This wide variety of HTA systems in the EU has impacted on the increasing gap between pricing and reimbursement of medicines and treatments, adding to the growing cost burden of funding healthcare...
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

Teva Pharmaceutical and Ranbaxy Settle With N.Y. AG Over "Unlawful ... - DailyFinance

Teva Pharmaceutical and Ranbaxy Settle With N.Y. AG Over "Unlawful ... - DailyFinance | Pharma Pricing and Market Access | Scoop.it
Financial Express
Teva Pharmaceutical and Ranbaxy Settle With N.Y. AG Over "Unlawful ...
more...
No comment yet.
Rescooped by Edmond Rama from Pharma in Emerging Markets
Scoop.it!

Actavis to Quit China as Trouble Seen for Little Profit

Actavis Plc, the second-biggest generic drugmaker by market capitalization, said it will end its presence in China because of the difficult business climate.

Via Aleksandra Misiorowska
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

EMA to expand orphan drug HTA collaboration - PMLiVE

EMA to expand orphan drug HTA collaboration - PMLiVE | Pharma Pricing and Market Access | Scoop.it
EMA to expand orphan drug HTA collaboration
PMLiVE
The European Medicines Agency (EMA) is set to continue to offer orphan drug manufacturers the opportunity to receive parallel advice on benefit-risk, significant benefit and relative effectiveness.
more...
No comment yet.
Scooped by Edmond Rama
Scoop.it!

Central and Eastern Europe OTC Drugs Industry Outlook to 2017- Expanding ... - SYS-CON Media (press release)

Central and Eastern Europe OTC Drugs Industry Outlook to 2017- Expanding ... - SYS-CON Media (press release) | Pharma Pricing and Market Access | Scoop.it
Central and Eastern Europe OTC Drugs Industry Outlook to 2017- Expanding ...
more...
No comment yet.
Rescooped by Edmond Rama from ONE Resource for Pharma & Biotech HEOR: Health Economics, Outcomes Research, Pricing, and Reimbursement
Scoop.it!

The world's largest pharmaceutical market access conference | Pharma Pricing

The world's largest pharmaceutical market access conference | Pharma Pricing | Pharma Pricing and Market Access | Scoop.it
The world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals. (@PharmaTimes G8t update on #valuebasedpricing Thanks!Will be discussed nxt month at our Pricing conf.

Via Patti Peeples
more...
No comment yet.